ESTHMR إستثمر

Memphis Pharmaceutical & Chemical Industries MPCI

ممفيس للادوية والصناعات الكيماوية

Health Care & PharmaceuticalsEgyptian Exchange

346.51 EGP

+5.45%

Close of Thu 1 Oct 2026

Market value
EGP 7.88bn
Highest and lowest close in a year
130.14 – 446.00
Shares traded in the session
295,831
Open the full company record in ESTHMR

A chart of every session, the financial statements, the nine checks and filing alerts. Free, with your e-mail and a six-digit code.

About the company

Memphis Pharmaceutical and Chemical Industries is a Cairo-based company operating in the pharmaceuticals, biotechnology, and life sciences sector, focusing on pharmaceuticals. Established in July 1940 and listed on the Egyptian Exchange since September 1995, it is majority-controlled by Holding Co for Pharmaceuticals with a 60.0384% stake. The company holds an 8.8% stake in Arab Company for Pharmaceutical and Medicinal Plants and 5.0% in Medical Profession Investment Co.

Facts from Mubasher

Its record at the exchange

Across 868 filings from 2010 to 2026, the company experienced trading suspensions 27 times and resumptions 24 times, with 2016 being its most active year at 68 filings. Out of 68 reported cumulative profit-or-loss periods from 2014 to 2026, 14 were loss-making. Its reported net results have ranged from a low of -47 million EGP in FY 2018 (to 30 Jun) to a high of 505 million EGP in FY 2025 (to 30 Jun).

Its latest filings at the exchange

  1. ResultsMemphis Pharmaceuticals and Chemical Industries (MPCI.CA) announces its financial results for the period ending on 30/06/2026
  2. Board decisionsMemphis Pharmaceuticals and Chemical Industries (MPCI.CA) - Company board of directors decisions
  3. Board decisionsMemphis Pharmaceuticals and Chemical Industries (MPCI.CA) - Company board of directors decisions

Insider trades in the exchange’s bulletin

As the exchange publishes them in each session’s bulletin: the trader’s capacity, not their name. Each row opens the bulletin itself.

  1. Insider / Board Sold200 (less than 0.01% of the company)Bulletin ↗
  2. Insider / Board Sold140 (less than 0.01% of the company)Bulletin ↗
  3. Insider / Board Bought225 (less than 0.01% of the company)Bulletin ↗
  4. Insider / Board Bought1,340 (less than 0.01% of the company)Bulletin ↗
  5. Insider / Board Sold1,497 (less than 0.01% of the company)Bulletin ↗
  6. Insider / Board Sold3 (less than 0.01% of the company)Bulletin ↗
  7. Insider / Board Sold50 (less than 0.01% of the company)Bulletin ↗

Other companies in Health Care & Pharmaceuticals

Page updated with the data of 1 Oct 2026.